CureVac Statements
5C
Data from CureVac`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
EUR - Euro
Last reporting period:
30 Jun, 2024
Next reporting period:
28 Sep, 2024
Report frequency:
Quarterly
Earnings release date:
15 Aug, 2024
Expected release date:
12 Nov, 2024
CureVac Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
14.436
16.7 %
100
40.723
282.1
-26.287
10.3 %
-182.09
25.291
175.2
14.707
101.9
44.31
0.2 %
306.9
-70.597
4 %
-489.03
2.378
16.5
—
0
-71.242
-1.9 %
-493.5
1.301
9
-72.543
-2.8 %
-502.5
-0.323
224.31
12.373
-45.2 %
100
41.69
336.9
-29.317
5.5 %
-236.9
25.985
210
17.843
144.2
44.222
-26.3 %
357.4
-73.539
19.2 %
-594.4
3.431
27.7
-0.001
-0.008
-69.887
19.2 %
-564.8
0.666
5.4
-70.553
18.6 %
-570.2
-0.31
227.59
22.567
36.9 %
100
53.596
237.5
-31.029
-297.9 %
-137.5
30.147
133.6
23.865
105.8
60.037
27.8 %
266
-91.066
-66.2 %
-403.5
1.526
6.8
—
0
-86.488
-77.7 %
-383.2
0.165
0.7
-86.653
-78 %
-384
-0.389
223.01
16.483
117.5 %
100
24.281
147.3
-7.798
57.3 %
-47.3
25.428
154.3
16.279
98.8
46.989
-12.9 %
285.1
-54.787
24.1 %
-332.4
5.361
32.5
—
0
-48.675
27.8 %
-295.3
0.006
0.04
-48.681
27.8 %
-295.3
-0.22
221.28
7.58
6.3 %
100
25.86
341.2
-18.28
-35.3 %
-241.2
29.08
383.6
20.68
272.8
53.93
14.4 %
711.5
-72.21
-19 %
-952.6
4.41
58.2
—
0
-67.39
-17.4 %
-889.05
0.03
0.4
-67.41
-17.4 %
-889.3
-0.3
223.88
7.13
-39 %
100
20.63
289.3
-13.51
80.2 %
-189.5
22.53
316
21.01
294.7
47.16
-11.5 %
661.4
-60.67
50.1 %
-850.9
2.94
41.2
—
0
-57.42
55.4 %
-805.3
—
0
-57.42
55.4 %
-805.3
-0.27
212.66
11.69
4.3 %
100
80
684.3
-68.31
-430.8 %
-584.3
22.83
195.3
24.94
213.3
53.26
33.9 %
455.6
-121.57
-130.9 %
-1039.9
-7.24
-61.9
—
0
-128.75
-170.2 %
-1101.4
0.03
0.3
-128.78
-170.7 %
-1101.6
-0.6
216.34
11.21
-44.4 %
100
24.08
214.8
-12.87
42.9 %
-114.8
10.77
96.1
23.99
214
39.78
5.2 %
354.9
-52.65
12.7 %
-469.7
4.73
42.2
—
0
-47.65
17.2 %
-425.07
-0.08
-0.7
-47.57
17.4 %
-424.4
-0.25
189.56
20.15
-17.3 %
100
42.68
211.8
-22.54
-75.3 %
-111.9
10.53
52.3
24.49
121.5
37.81
1424.6 %
187.6
-60.34
-293.4 %
-299.5
2.73
13.5
—
0
-57.57
-279 %
-285.7
0.01
0.05
-57.58
-281.6 %
-285.8
-0.31
187.05
24.37
-40.9 %
100
37.23
152.8
-12.86
55.3 %
-52.8
9.77
40.1
21.88
89.8
2.48
111.7 %
10.2
-15.34
-101.8 %
-62.9
0.08
0.3
—
0
-15.19
-233.1 %
-62.3
-0.1
-0.4
-15.09
-677.8 %
-61.9
-0.08
187.03
41.23
582.6 %
100
70.02
169.8
-28.79
-2565.7 %
-69.8
529.97
1285.4
16.79
40.7
-21.19
-146.5 %
-51.4
-7.6
83.7 %
-18.4
0.95
2.3
—
0
-4.56
92 %
-11.06
-2.62
-6.4
-1.94
96.7 %
-4.7
-0.01
191.37
6.04
93.6 %
100
7.12
117.9
-1.08
54.2 %
-17.9
37.47
620.4
20.33
336.6
45.56
104.2 %
754.3
-46.64
-89.1 %
-772.2
-10.62
-175.8
—
0
-57.26
-139.7 %
-948.01
0.89
14.7
-58.15
-143.8 %
-962.7
-0.31
187.94
3.12
—
100
5.48
175.6
-2.36
—
-75.6
10.55
338.1
11.37
364.4
22.31
—
715.1
-24.67
—
-790.7
-0.68
-21.8
—
0
-23.89
—
-765.7
-0.04
-1.3
-23.85
—
-764.4
-0.14
176.46